Skip to main content

Table 2 General description and clinical manifestations of the study population

From: PPBP and DEFA1/DEFA3 genes in hyperlipidaemia as feasible synergistic inflammatory biomarkers for coronary heart disease

Variable

Age (year)

TC (mg/dL)

LDL (mg/dL)

TG (mg/dL)

HDL (mg/dL)

Normal

42 (23–58)

175 (156–199)

99 (60–111)

147 (70–162)

41 (31–56)

Hyperlipidaemia

42 (26–58)

223 (150–304)b

131 (63–190)c

166 (103–1181)d

46 (26–80)

Coronary Heart Disease

(CHD)

66 (58–78)a

166 (115–259)

89 (44–174)

92 (72–169)

49 (37–75)

  1. All patients and controls were male. N normal controls, H and CHD patients with hyperlipidaemia and coronary heart disease, respectively, TC total cholesterol, TG triglyceride, HDL high-density lipoprotein, LDL low-density lipoprotein
  2. Data are shown as medians (ranges). The differences in each variable between two groups (N vs. H, H vs. CHD, and N vs. CHD) were determined using the Mann–Whitney U test. The α level was set at <0.05 at a 95% confidence interval. The significantly different variables between groups are as follows
  3. a Age of the patients with CHD was significantly more than N and H groups (p = 0.000)
  4. b Levels of TC in H were significantly higher than those in N (p = 0.004) and CHD groups (p = 0.008)
  5. c LDL levels in H was tended to higher than in N groups (p = 0.072), and significantly higher than in CHD group (p = 0.049)
  6. d There was significant difference in TG levels; H > CHD (p = 0.013); N > CHD (p = 0.025)